Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Other Operating Expenses (2023 - 2025)

Kezar Life Sciences (KZR) has disclosed Other Operating Expenses for 3 consecutive years, with $6.8 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses rose 57075.0% to $6.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.8 million through Dec 2025, up 365.1% year-over-year, with the annual reading at $6.8 million for FY2025, 365.1% up from the prior year.
  • Other Operating Expenses hit $6.8 million in Q4 2025 for Kezar Life Sciences, up from -$12000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $6.8 million in Q4 2025 to a low of -$12000.0 in Q4 2024.
  • Historically, Other Operating Expenses has averaged $3.6 million across 3 years, with a median of $3.8 million in 2023.
  • Biggest five-year swings in Other Operating Expenses: tumbled 100.19% in 2024 and later skyrocketed 57075.0% in 2025.
  • Year by year, Other Operating Expenses stood at $6.2 million in 2023, then plummeted by 100.19% to -$12000.0 in 2024, then surged by 57075.0% to $6.8 million in 2025.
  • Business Quant data shows Other Operating Expenses for KZR at $6.8 million in Q4 2025, -$12000.0 in Q4 2024, and $1.5 million in Q2 2024.